Radiation applied to health Archives - Page 4 of 4

admin In Active, Medical Devices and In Vitro Diagnostics, Radiation applied to health, Regional

Modular 01

Modular 01 project consists of the development of a new generation synthesizer dedicated to the production of radiopharmaceuticals used as diagnostic (tracers) or therapies. The system is made of different sub-modules for the radioisotope management, the labeling step, the post labeling chemistries and the final purification / formulation. These sub modules can...

admin In Active, Medical Devices and In Vitro Diagnostics, Radiation applied to health, Regional

CardiAmmonia

Project co-led by MecaTech and BioWin Today, nuclear medicine PET (Positron Emission Tomography) also extends to neurology and cardiology. Nuclear cardiology uses noninvasive myocardial perfusion examination techniques to evaluate the pumping capacity of the heart and to detect the presence of ischemia or lesions. High quality imaging of PET scanners...

admin In Active, Radiation applied to health, Regional

Arc Protonthérapie

Project co-led by MecaTech and BioWin. The project aims to develop an innovative variation of the classical technique of delivery of proton therapy by intensity modulation. This new technique is called "Arc Protontherapy". This new technique allows to deliver the dose continuously during rotation of the gantry. For the patient, Arc...

admin In Active, Biopharmacy, Radiation applied to health, Regional

FAR

When surgical removal is not possible, oncologists have few treatment options to offer their cancer patients. Trasis, Xpress Biologics, CMMI (ULB) and UMONS are embarking on the FAR (Fragments of Antibodies for Radioimmunotherapy) research project to promote the use of antibody fragments as carriers of radioactive isotopes. By using both the ability of antibody fragments to target tumours and...

admin In Active, Biopharmacy, Radiation applied to health, Regional

M2-TARGET

M2-Target aims to develop a non-invasive imaging method for the detection and quantification of M2 macrophages. This method is based on a new radiotracer (called 68Ga-ABSCINT-206) initially developed at the Vrije Universiteit Brussel (VUB). It is composed of a single-domain antibody fragment (also called "nanobodies") that recognizes a receptor (CD206)...

admin In Active, Medical Devices and In Vitro Diagnostics, Radiation applied to health, Regional

EPT-1

(MecaTech R&I project, followed by BioWin) IBA, Jobs & Project partner and V2I with UCL and UNamur to define the future of Proton Therapy delivery techniques with FLASH and Grid Therapies. Proton therapy is the most advanced form of radiotherapy in the fight against cancer. The unique dose deposition enables...

Previous 1 2 3 4